Proteomics Market Set To Surge: Aiming For USD 96.35 Billion By 2032, Driven By Rising Demand For Personalized Medicine And Technological Advancements

(MENAFN- GlobeNewsWire - Nasdaq) Growth in Drug Discovery, Government Funding, and Innovations in Bioinformatics Propel the Proteomics Industry

Austin, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Proteomics Market Size Analysis:

“According to S&S Insider, The Proteomics Market was valued at USD 30.61 billion in 2023 and is projected to grow to USD 96.35 billion by 2032, expanding at a compound annual growth rate (CAGR) of 13.61% during the forecast period of 2024-2032.”

The proteomics market is witnessing significant growth due to advancements in personalized medicine and drug discovery. As the demand for tailored treatments rises and proteomics plays a pivotal role in biomarker discovery, the market is expected to thrive over the forecast period.

Get a Sample Report of Proteomics Market@

Market Overview:

Rising prevalence of chronic diseases like cancer and proteomics market is classified as largest growing segment due to advancement in biotechnology, continued adoption of precision or personalized medicine and increased focus on drug discovery. Advanced proteomic technologies that allow for more comprehensive protein function, interaction and expression pattern analysis are bolstering the progress of proteomics-based therapeutics in key therapeutic areas like oncology, immunology and neurology. Recent advancements in biotechnology and the increasing adoption of precision medicine are pivotal factors driving the proteomics market, particularly in addressing diseases like cancer, diabetes, and neurological disorders. The rising incidence of chronic conditions, especially cancer, is significantly influencing market dynamics. The American Cancer Society forecasts that the number of cancer cases could reach 35 million annually by 2050, a trend attributed to the aging population and lifestyle changes​

Leading factors like high utilization of mass spectrometry globally and a growing need for faster, accurate diagnostic tools is providing traction to the growth of this market. These innovations will allow for biomarker discovery, disease mechanisms and targeted therapy development. Moreover, AI and ML implementation into proteomics is playing a major role in drug development and clinical diagnostics as well, which is a significant factor driving the market. Proteomics has been increasingly employed in personalized medicine and clinical diagnostics which rapidly drives this growth.

Proteomics Market Technological developments, government incentives and rising investments in biotech and health related research are some of the key drivers for Proteomics market. Increasing demand for biomarker discovery and development of the complicated diseases such as cancer, diabetes & other neurological disorders is pervasive lucrative opportunities. Coupled with public and private investment driven by exploratory efforts around the world, proteomics market will continue to grow.

Biotechnology company expansion, molecular biology advancements and increased proteomics-genomics integration are supporting market growth. Also, the increasing need for specific therapies and personalized medicine has made proteomics essential in clinical assays, drug development, and diagnostics particularly for finding molecular targets, measuring anti-drug effectiveness or therapeutic responses to a given treatment.

Proteomics Market Report Scope:

Report Attributes	Details
Market Size in 2023	US$ 30.61 Billion
Market Size by 2032	US$ 96.35 Billion
CAGR	CAGR of 13.61% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Regional Analysis/Coverage	North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America)
Key Drivers	Improved technologies enhance protein analysis precision, vital for complex research like disease biomarker identification. Proteomics offers insights for tailored treatments by identifying specific biomarkers for diseases like cancer and cardiovascular conditions.

Need any customization research on Proteomics Market, Enquire Now@

Major Players Analysis Listed in this Report are:

• Thermo Fisher Scientific
• Agilent Technologies
• Waters Corporation
• PerkinElmer
• Bio-Rad Laboratories
• Abcam
• GE Healthcare Life Sciences
• Danaher Corporation
• Bruker Corporation
• Qiagen
• Merck KGaA
• Promega Corporation
• Illumina
• Sartorius AG
• Shimadzu Corporation
• Agilent Technologies
• Sysmex Corporation
• Pacific Biosciences
• Roche Diagnostics
• Becton, Dickinson and Company

Segmentation Analysis

By Technology

In 2023, the spectrometry segment dominated the market and represented significant revenue share. Spectrometry is essential for protein identification, characterization, detecting post-translational modifications, and analyzing protein-protein interactions. Advancements in mass spectrometry, such as improved resolution, faster speeds, and greater automation, have significantly boosted its efficiency, solidifying its role as a preferred method in proteomics research. Moreover, integrating spectrometry with bioinformatics has expanded its use in drug discovery, biomarker identification, and personalized medicine, fueling continued segment growth.

The next-generation sequencing (NGS) segment is also set for rapid expansion from 2024 to 2032, largely driven by decreasing sequencing costs, which have made NGS technology more accessible across a wide array of research and clinical fields. Technological improvements that enhance speed and accuracy are accelerating NGS adoption in oncology, genetic disease research, and personalized medicine. To capitalize on this trend, companies are taking strategic actions, such as the February 2024 partnership between Pixelgen Technologies and BioStream Co. Ltd., which aims to distribute next-generation sequencing spatial proteomics tools for single-cell applications. These efforts are likely to accelerate the growth of the NGS segment further.

Proteomics Market Key Segmentation:

By Product & Services

• Instruments
• Reagents & Consumables
• Services

By Application

• Drug Discovery
• Clinical Diagnostics
• Others

By Technology

• Next-generation Sequencing
• Microarray Instruments
• X-Ray Crystallography
• Spectrometry
• Chromatography
• Protein Fractionation Systems
• Electrophoresis
• Surface Plasma Resonance (SPR) Systems
• Other Technologies

Request An Analyst Call@

Regional Landscape

In 2023, North America dominated the global proteomics market, holding over 46.87% of the total market share. This leadership is driven by key factors such as technological advancements and the growing demand for advanced diagnostic tools for a variety of diseases. The region also benefits from substantial investments in precision medicine and robust government funding in biotechnology and healthcare, providing a strong foundation for market growth. In the U.S., a thriving biotechnology and life sciences research sector, coupled with advancements in mass spectrometry and the presence of major industry players, continues to fuel this expansion.

The Asia Pacific proteomics market is projected to experience the highest growth, with an anticipated compound annual growth rate (CAGR) of 16.47% between 2024 and 2032. This growth is propelled by factors like the rising prevalence of chronic diseases, an increasing trend toward outsourcing proteomics projects, and increased public and private sector investments, bolstered by favorable government policies. The region's strong biotechnology and biopharmaceutical presence, especially in Japan, where initiatives in drug discovery, personalized medicine, and ongoing technological advancements are supported by government-backed efforts, will further accelerate market expansion.

Recent Developments

In July 2024, Agilent Technologies unveiled the Agilent ExD Cell, designed to enhance protein and peptide characterization when paired with the 6545XT AdvanceBio LC/Q-TOF system. This innovation is expected to improve the accuracy and efficiency of proteomics analysis in clinical and research settings.

In February 2024, Thermo Fisher Scientific launched the Orbitrap Fusion Lumos Mass Spectrometer, which integrates next-generation mass spectrometry for more precise protein identification, playing a key role in advancing proteomics research in drug discovery and disease diagnostics.

Buy a Single-User PDF of Proteomics Market Analysis & Outlook Report 2024-2032@

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

• Incidence and Prevalence (2023)
• Prescription Trends, (2023), by Region
• Device Volume, by Region (2020-2032)
• Ambulatory Surgical Centers Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023

6. Competitive Landscape

7. Proteomics Market Segmentation, by Product & Services

8. Proteomics Market Segmentation, by Application

9. Proteomics Market Segmentation, by Technology

10. Regional Analysis

11. Company Profiles

12. Use Cases and Best Practices

13. Conclusion

Access Complete Report Details of Proteomics Market Analysis & Outlook 2024-2032@

About Us:

S&S Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Akash Anand – Head of Business Development & Strategy ... Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

MENAFN08112024004107003653ID1108865737